全文获取类型
收费全文 | 869994篇 |
免费 | 72643篇 |
国内免费 | 2978篇 |
专业分类
耳鼻咽喉 | 12896篇 |
儿科学 | 24695篇 |
妇产科学 | 25307篇 |
基础医学 | 124867篇 |
口腔科学 | 25763篇 |
临床医学 | 76916篇 |
内科学 | 165028篇 |
皮肤病学 | 17060篇 |
神经病学 | 70352篇 |
特种医学 | 35750篇 |
外国民族医学 | 182篇 |
外科学 | 137171篇 |
综合类 | 26890篇 |
现状与发展 | 5篇 |
一般理论 | 265篇 |
预防医学 | 67197篇 |
眼科学 | 20821篇 |
药学 | 65968篇 |
11篇 | |
中国医学 | 2374篇 |
肿瘤学 | 46097篇 |
出版年
2018年 | 7866篇 |
2015年 | 8383篇 |
2014年 | 11929篇 |
2013年 | 17460篇 |
2012年 | 23764篇 |
2011年 | 24997篇 |
2010年 | 14542篇 |
2009年 | 13686篇 |
2008年 | 23338篇 |
2007年 | 25349篇 |
2006年 | 25205篇 |
2005年 | 24872篇 |
2004年 | 24168篇 |
2003年 | 23250篇 |
2002年 | 22291篇 |
2001年 | 36060篇 |
2000年 | 36698篇 |
1999年 | 31032篇 |
1998年 | 8917篇 |
1997年 | 8126篇 |
1996年 | 8007篇 |
1995年 | 8137篇 |
1994年 | 7800篇 |
1992年 | 26733篇 |
1991年 | 26172篇 |
1990年 | 25676篇 |
1989年 | 24728篇 |
1988年 | 23247篇 |
1987年 | 22921篇 |
1986年 | 21767篇 |
1985年 | 21135篇 |
1984年 | 16377篇 |
1983年 | 13966篇 |
1982年 | 8826篇 |
1981年 | 8167篇 |
1980年 | 7630篇 |
1979年 | 16698篇 |
1978年 | 12076篇 |
1977年 | 10138篇 |
1976年 | 9291篇 |
1975年 | 10109篇 |
1974年 | 12615篇 |
1973年 | 12118篇 |
1972年 | 11523篇 |
1971年 | 10669篇 |
1970年 | 10195篇 |
1969年 | 9894篇 |
1968年 | 8890篇 |
1967年 | 8212篇 |
1966年 | 7640篇 |
排序方式: 共有10000条查询结果,搜索用时 406 毫秒
51.
S. M. White C. L. Shelton A. W. Gelb C. Lawson F. McGain J. Muret J. D. Sherman representing the World Federation of Societies of Anaesthesiologists Global Working Group on Environmental Sustainability in Anaesthesia 《Anaesthesia》2022,77(2):201-212
The Earth’s mean surface temperature is already approximately 1.1°C higher than pre-industrial levels. Exceeding a mean 1.5°C rise by 2050 will make global adaptation to the consequences of climate change less possible. To protect public health, anaesthesia providers need to reduce the contribution their practice makes to global warming. We convened a Working Group of 45 anaesthesia providers with a recognised interest in sustainability, and used a three-stage modified Delphi consensus process to agree on principles of environmentally sustainable anaesthesia that are achievable worldwide. The Working Group agreed on the following three important underlying statements: patient safety should not be compromised by sustainable anaesthetic practices; high-, middle- and low-income countries should support each other appropriately in delivering sustainable healthcare (including anaesthesia); and healthcare systems should be mandated to reduce their contribution to global warming. We set out seven fundamental principles to guide anaesthesia providers in the move to environmentally sustainable practice, including: choice of medications and equipment; minimising waste and overuse of resources; and addressing environmental sustainability in anaesthetists’ education, research, quality improvement and local healthcare leadership activities. These changes are achievable with minimal material resource and financial investment, and should undergo re-evaluation and updates as better evidence is published. This paper discusses each principle individually, and directs readers towards further important references. 相似文献
52.
Dave E. W. van der Kruijssen Auke J. S. van der Kuil Geraldine R. Vink Cornelis J. A. Punt Johannes H. W. de Wilt Sjoerd G. Elias Miriam Koopman 《International journal of cancer. Journal international du cancer》2023,152(7):1360-1369
We studied the prognostic value of primary tumor sidedness in metastatic colorectal cancer over time and across treatment lines. Population data on synchronous metastatic colorectal cancer patients were extracted from the Netherlands Cancer Registry and SEER database. Pubmed, EMBASE and Cochrane library were searched for prospective studies on metastatic colorectal cancer to conduct a meta-analysis. Inclusion criteria consisted of metastatic disease, systemic treatment with palliative intent and specification of primary tumor location. Data were pooled using a random-effects model. For the population-based data, multivariable Cox models were constructed. The Grambsch-Therneau test was conducted to evaluate the potential time-varying nature of sidedness. Meta-regression incorporating treatment-line as variable was conducted to test the pre-specified hypothesis that the prognostic value of sidedness varies over time. Analysis of 12 885 and 16 160 synchronous metastatic colorectal cancer patients registered in the Netherlands Cancer Registry and SEER database, respectively, indicated a time-varying prognostic value of sidedness (P < .01). Thirty-one studies were selected for the meta-analysis (9558 patients for overall survival analysis). Pooled univariable hazard ratioleft-sided/right-sided for overall survival was 0.71 (95% CI: 0.65-0.76) in 1st-line, 0.76 (0.54-1.06) in 2nd-line and 1.01 (0.86-1.19) in 3rd-line studies. Hazard ratios were significantly influenced by treatment line (P = .035). The prognostic value of sidedness of the primary tumor in metastatic colorectal cancer patients treated with palliative systemic therapy decreases over time since diagnosis, suggesting that sidedness may not be a useful stratification factor in late-line trials. This decrease in prognostic value should be taken into account when providing prognostic information to patients. 相似文献
53.
54.
Stefaniuk Catherine M. Schlegelmilch June Meyerson Howard J. Harding Clifford V. Maitta Robert W. 《Journal of thrombosis and thrombolysis》2022,53(4):950-953
Journal of Thrombosis and Thrombolysis - Over the last few years data from our group have indicated that α-synuclein is important in development of immune cells as well as potentially... 相似文献
55.
Structured data sets can be created from cytology reports without the addition of synoptic reports using either natural language processing or minor changes to laboratory information systems structure.; 相似文献
56.
57.
目的 观察具有益气化痰活血作用的冠心康对人单核/巨噬细胞株THP-1细胞PERK-eIF2α信号通路及相关活化转录因子(ATF)和C/EBP同源转录因子(CHOP)的影响,探究冠心康对胆固醇在巨噬细胞内质网中的代谢稳态调节及作为“脂毒”流出后异常沉积的相关作用。方法 采用100 ng·mL-1 PMA及80 μg·mL-1氧化低密度脂蛋白诱导THP-1细胞株,构建巨噬细胞模型,并随机分为模型组、冠心康组、辛伐他汀组、正常组。分别采用10%小牛血清及含药血清干预模型细胞72 h后收集细胞。HE染色观察巨噬细胞病理形态变化,同时进行胆固醇及脂滴含量测定。分别采用Real-time PCR及Western blot法检测各组细胞PERK、eIF2α、ATF、CHOP mRNA及蛋白的表达。结果 HE染色观察到模型组细胞内呈现较多红色脂滴,经胆固醇含量测定,明显高于正常组,脂滴含量测定与前者一致(P<0.01)。模型组细胞ATF、CHOP基因表达水平均显著升高(P<0.01)。与模型组比较,冠心康组和辛伐他汀组细胞ATF、CHOP基因表达水平均显著降低(P<0.01)。PERK磷酸化以及CHOP蛋白表达水平在冠心康和辛伐他汀干预组表现为显著下调,与模型组比较,差异具有统计学意义(P<0.05)。结论 冠心康可能通过调控PERK-eIF2α-CHOP通路相关基因及蛋白,减少泡沫细胞形成,从而减轻内质网应激,维持细胞内胆固醇稳态,减少细胞内胆固醇沉积。 相似文献
58.
59.
Tie Zhou Shengfei Qin Weidong Xu Shouyan Tang Guanghua Chen Song Li Jianguo Hou Xu Gao Guowei Shi Zhongquan Sun Jie Jin Lijun Chen Weibing Sun Ben Liu Jingen Wang Qinggui Meng Dongwen Wang Zhiquan Hu Dalin He Yong Yang Xishuang Song Cheng Fu Yinhuai Wang Dingwei Ye Wei Zhang 《International journal of cancer. Journal international du cancer》2023,153(4):792-802
We aim to assess the safety and efficacy of proxalutamide, a novel androgen receptor antagonist, for men with metastatic castration-resistant prostate cancer (mCRPC) in a multicenter, randomized, open-label, phase 2 trial. In our study, the enrolled mCRPC patients were randomized to 100, 200 and 300 mg dose groups at 1:1:1. The primary efficacy endpoint was prostate-specific antigen (PSA) response rate. The secondary endpoints included objective response rate (ORR), disease control rate (DCR) and time to PSA and radiographic progression. Safety and pharmacokinetics were also assessed. Finally, there were 108 patients from 17 centers being enrolled. By week 16, there were 13 (35.1%), 12 (36.4%) and 15 (42.9%) patients with confirmed 50% or greater PSA decline in 100 mg (n = 37), 200 mg (n = 33) and 300 mg (n = 35) groups, respectively. Among the 19 patients with target lesions at study entry, three (15.8%) had a partial response and 12 (63.2%) had stable disease. The ORRs of 20.0%, 22.2%, 0% and DCRs of 80.0%, 88.9%, 60.0% were, respectively, achieved in 100, 200 and 300 mg groups. By the maximum follow-up time of 24 weeks, there were 42.6% and 10.2% of cases experiencing PSA progression and radiographic progression, respectively. Overall, adverse events (AEs) were experienced by 94.4% of patients, most of which were mild or moderate. There were 28 patients experiencing ≥grade 3 AEs. The most common AEs were fatigue (17.6%), anemia (14.8%), elevated AST (14.8%) and ALT (13.0%), decreased appetite (13.0%). These findings preliminarily showed the promising antitumor activity of proxalutamide in patients with mCRPC with a manageable safety profile. The proxalutamide dose of 200 mg daily is recommended for future phase 3 trial (Clinical trial registration no. CTR20170177). 相似文献